Cargando…

Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients

BACKGROUND: In pediatric tumors, immunotherapy exhibits less toxicity than chemotherapy and radiation. The current study aims to identify potential immune targets in immune-related genes of C-C motif chemokine ligand genes (CCLs) and C-C motif chemokine receptors (CCRs) in childhood osteosarcoma (OS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zide, Liu, Chong, Liang, Tuo, Yu, Chaojie, Qin, Zhaojie, Zhou, Xin, Xue, Jiang, Zeng, Haopeng, Lu, Zhaojun, Xu, Guoyong, Wang, Zequn, Chen, Jiarui, Jiang, Jie, Zhan, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668544/
https://www.ncbi.nlm.nih.gov/pubmed/33181717
http://dx.doi.org/10.1097/MD.0000000000023251
_version_ 1783610507174871040
author Zhang, Zide
Liu, Chong
Liang, Tuo
Yu, Chaojie
Qin, Zhaojie
Zhou, Xin
Xue, Jiang
Zeng, Haopeng
Lu, Zhaojun
Xu, Guoyong
Wang, Zequn
Chen, Jiarui
Jiang, Jie
Zhan, Xinli
author_facet Zhang, Zide
Liu, Chong
Liang, Tuo
Yu, Chaojie
Qin, Zhaojie
Zhou, Xin
Xue, Jiang
Zeng, Haopeng
Lu, Zhaojun
Xu, Guoyong
Wang, Zequn
Chen, Jiarui
Jiang, Jie
Zhan, Xinli
author_sort Zhang, Zide
collection PubMed
description BACKGROUND: In pediatric tumors, immunotherapy exhibits less toxicity than chemotherapy and radiation. The current study aims to identify potential immune targets in immune-related genes of C-C motif chemokine ligand genes (CCLs) and C-C motif chemokine receptors (CCRs) in childhood osteosarcoma (OS) and to explore the underlying molecular mechanisms of childhood OS. METHODS: Firstly, we identified immune-related genes in CCLs and CCRs, these genes were used for functional annotation and interaction analysis. Then, the prognostic value of these genes was evaluated using Kaplan-Meier analysis and multivariate COX regression model. And the potential relationship between risk score and immune infiltrating cells was identified. Finally, gene set enrichment analysis was used to determine the underlying molecular mechanism of OS. Immune-related genes in CCLs and CCRs are inextricably linked. RESULTS: The results of survival analysis of these genes show that CCL5, CCL8, CCR4, and CCR5 are significantly associated with the prognosis of childhood OS. The combined effect survival analysis shows that the co-high expression of these 4 genes has a good prognosis for childhood OS. A prognostic signature model was constructed based on the 4 genes mentioned above, and the result of time-dependent receiver operating characteristic curves showed that this model was a good predictor of childhood OS 3- and 5-year prognosis. In addition, the risk score of the constructed prognostic signature model was closely related to immune infiltration. We also found that CCL5, CCL8, and CCR5 may affect the prognosis of OS through complex regulation among Toll-like receptor signaling pathway, mitogen-activated protein kinase (MAPK) family signaling cascade, and nuclear factor-kappaB pathway, whereas CCR4 affects the prognosis of OS by regulating eukaryotic translation. CONCLUSION: CCL5, CCL8, CCR4, and CCR5 are potential prognostic markers for the prognosis of childhood OS, and the underlying molecular mechanisms of childhood OS have been identified.
format Online
Article
Text
id pubmed-7668544
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76685442020-11-17 Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients Zhang, Zide Liu, Chong Liang, Tuo Yu, Chaojie Qin, Zhaojie Zhou, Xin Xue, Jiang Zeng, Haopeng Lu, Zhaojun Xu, Guoyong Wang, Zequn Chen, Jiarui Jiang, Jie Zhan, Xinli Medicine (Baltimore) 5700 BACKGROUND: In pediatric tumors, immunotherapy exhibits less toxicity than chemotherapy and radiation. The current study aims to identify potential immune targets in immune-related genes of C-C motif chemokine ligand genes (CCLs) and C-C motif chemokine receptors (CCRs) in childhood osteosarcoma (OS) and to explore the underlying molecular mechanisms of childhood OS. METHODS: Firstly, we identified immune-related genes in CCLs and CCRs, these genes were used for functional annotation and interaction analysis. Then, the prognostic value of these genes was evaluated using Kaplan-Meier analysis and multivariate COX regression model. And the potential relationship between risk score and immune infiltrating cells was identified. Finally, gene set enrichment analysis was used to determine the underlying molecular mechanism of OS. Immune-related genes in CCLs and CCRs are inextricably linked. RESULTS: The results of survival analysis of these genes show that CCL5, CCL8, CCR4, and CCR5 are significantly associated with the prognosis of childhood OS. The combined effect survival analysis shows that the co-high expression of these 4 genes has a good prognosis for childhood OS. A prognostic signature model was constructed based on the 4 genes mentioned above, and the result of time-dependent receiver operating characteristic curves showed that this model was a good predictor of childhood OS 3- and 5-year prognosis. In addition, the risk score of the constructed prognostic signature model was closely related to immune infiltration. We also found that CCL5, CCL8, and CCR5 may affect the prognosis of OS through complex regulation among Toll-like receptor signaling pathway, mitogen-activated protein kinase (MAPK) family signaling cascade, and nuclear factor-kappaB pathway, whereas CCR4 affects the prognosis of OS by regulating eukaryotic translation. CONCLUSION: CCL5, CCL8, CCR4, and CCR5 are potential prognostic markers for the prognosis of childhood OS, and the underlying molecular mechanisms of childhood OS have been identified. Lippincott Williams & Wilkins 2020-11-13 /pmc/articles/PMC7668544/ /pubmed/33181717 http://dx.doi.org/10.1097/MD.0000000000023251 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5700
Zhang, Zide
Liu, Chong
Liang, Tuo
Yu, Chaojie
Qin, Zhaojie
Zhou, Xin
Xue, Jiang
Zeng, Haopeng
Lu, Zhaojun
Xu, Guoyong
Wang, Zequn
Chen, Jiarui
Jiang, Jie
Zhan, Xinli
Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title_full Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title_fullStr Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title_full_unstemmed Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title_short Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
title_sort establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668544/
https://www.ncbi.nlm.nih.gov/pubmed/33181717
http://dx.doi.org/10.1097/MD.0000000000023251
work_keys_str_mv AT zhangzide establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT liuchong establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT liangtuo establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT yuchaojie establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT qinzhaojie establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT zhouxin establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT xuejiang establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT zenghaopeng establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT luzhaojun establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT xuguoyong establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT wangzequn establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT chenjiarui establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT jiangjie establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients
AT zhanxinli establishmentofimmuneprognosticsignatureandanalysisofprospectivemolecularmechanismsinchildhoodosteosarcomapatients